Table of Content
1. INTRODUCTION
1.1. OVERVIEW OF THE EUROPE ELECTROPHYSIOLOGY MARKET
1.2. MARKET SEGMENTATION & COVERAGE
1.2.1. CURRENCY AND PRICING
1.2.2. LIMITATION
1.2.3. STAKEHOLDERS
2. RESEARCH METHODOLOGY
2.1. KEY TAKEAWAYS
2.2. ARRIVING AT THE EUROPE ELECTROPHYSIOLOGY MARKET SIZE
2.2.1. MARKET CRACKDOWN APPROACH
2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS
2.2.3. DATA TRIANGULATION
2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES
2.2.5. PRODUCT PIPELINE ANALYSIS
2.2.6. PORTER’S FIVE FORCES MATRIX
3. MARKET LANDSCAPE SUMMARY
4. PREMIUM INSIGHTS
4.1. OVERVIEW
4.2. EUROPE ELECTROPHYSIOLOGY MARKET: KEY PRIMARY INSIGHTS
4.3. MARKET OVERVIEW
4.3.1. DRIVERS
4.3.1.1. RISING PREVALENCE OF CHRONIC DISEASE SUCH AS CARDIOVASCULAR DISEASES
4.3.1.2. INCREASED PATIENT AWARENESS ABOUT DISGNOSIS AND TREATMENT
4.3.1.3. AGEING EUROPE POPULATION
4.3.1.4. NUMBER OF CARDIAC DEVICE IMPLANTATIONS
4.3.2. RESTRAINTS
4.3.3. OPPURTUNITIES
4.3.4. THREATS
4.4. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES
5. EXECUTIVE SUMMARY
6. EUROPE ELECTROPHYSIOLOGY MARKET, BY TYPE
6.1. OVERVIEW
6.2. EUROPE ELECTROPHYSIOLOGY, BY TYPE
6.2.1. ELECTROPHYSIOLOGY MONITORING DEVICES
6.2.1.1. ELECTROCARDIOLOGY
6.2.1.2. HOLTER MONITORING DEVICES
6.2.1.3. EVENT MONITORS
6.2.1.4. DIAGNOSTIC CATHETERS
6.2.1.5. X-RAY SYSTEMS
6.2.2. ELECTROPHYSIOLOGY TREATMENT DEVICES
6.2.2.1. ABLATION CATHETERS
6.2.1.2. PACE MAKERS
6.2.1.3. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
6.2.1.4. CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS (CRT-D)
6.2.1.5. CARDIAC RESYNCHRONIZATION THERAPY PACEMAKERS (CRT-P)
6.2.1.4. IMPLANTABLE LOOP RECORDERS
7. EUROPE ELECTROPHYSIOLOGY MARKET, BY PRODUCT TYPE
7.1. OVERVIEW
7.2. EUROPE ELECTROPHYSIOLOGY, BY PRODUCT TYPE
7.2.1. ELECTROPHYSIOLOGY ABLATION CATHETERS
7.2.1.1. RADIOFREQUENCY
7.2.1.2. CRYOBLATION
7.2.1.3. LASER ABLATION
7.2.1.4. NAVIGATIONAL ADVANCED MAPPING ACCESSORIES
7.2.1.5. MICROWAVE
7.2.2. ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS
7.2.2.1. CONVENTIONAL EP DIAGNOSTIC CATETERS
7.2.1.2. ADVANCED EP DIAGNOSTIC
7.2.1.3. ULTRASOUND EP DIAGNOSTIC
7.2.3. ELECTROPHYSIOLOGY LABORATORY DEVICES
7.2.1.1. X-RAY SYSTEMS
7.2.1.2. 3-D MAPPING SYSTEMS
7.2.1.3. REMOTE STEERING SYSTEMS
7.2.1.4. INTRA CARDIAC ECHOCARDIOGRAPHIC SYSTEMS(ICE)
7.2.1.5. RADIO FREQUENCY (RF) ABLATION GENERATORS
7.2.1.6. EP RECORDING SYSTEMS
7.2.4. ACCESS DEVICES
8. EUROPE ELECTROPHYSIOLOGY MARKET, BY INDICATION
8.1. OVERVIEW
8.2. EUROPE ELECTROPHYSIOLOGY, BY INDICATION
8.2.1. ATRIAL FIBRILLATION
8.2.2. ATRIAL FLUTTER
8.2.3. VENTRICULAR FIBRILLATION
8.2.4. VENTRICULAR TACHYCARDIA
8.2.1. ATRIAL TACHYCARDIA
8.2.2. WOLFF- PARKINSON- WHITE SYNDROME(WPW)
8.2.3. ATRIOVENTRICULAR NODAL REENTRY TACHYCARDIA
9. EUROPE ELECTROPHYSIOLOGY MARKET, BY GEOGRAPHY
9.1. COUNTRYWISE EUROPE ELECTROPHYSIOLOGY MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
9.1.1. EUROPE
9.1.2.1. GERMANY
9.1.2.2. FRANCE
9.1.2.3. U.K.
9.1.2.4. ITALY
9.1.2.5. SPAIN
9.1.2.6. RUSSIA
9.1.2.7. TURKEY
9.1.2.8. BELGIUM
9.1.2.9. NETHERLANDS
9.1.2.10. SWITZERLAND
9.1.2.11. REST OF EUROPE
9.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
10. EUROPE ELECTROPHYSIOLOGY MARKET: COMPETITIVE LANDSCAPE
10.1. EUROPE ELECTROPHYSIOLOGY MARKET : COMPANY SHARE ANALYSIS
10.2. GERMANY ELECTROPHYSIOLOGY MARKET MARKET: COMPANY SHARE ANALYSIS
10.3. FRANCE ELECTROPHYSIOLOGY MARKET MARKET: COMPANY SHARE ANALYSIS
10.4. U.K. ELECTROPHYSIOLOGY MARKET: COMPANY SHARE ANALYSIS
10.5. MERGERS & ACQUISITIONS
10.6. NEW PRODUCT DEVELOPMENT & APPROVALS
10.7. EXPANSIONS
10.8. REGULATORY CHANGES
10.9. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
11. GERMANY ELECTROPHYSIOLOGY MARKET: COMPANY SHARE ANALYSIS, COMPANY PROFILES
11.1. ABOTT LABORATORIES
11.1.1. COMPANY OVERVIEW
11.1.2. REVENUE ANALYSIS
11.1.3. PRODUCT PORTFOLIO
11.1.4. RECENT DEVELOPEMENTS
11.1.5. DATA BRIDGE ANALYSIS
11.2. BIOTRONIK SE & CO. KG
11.2.1. COMPANY OVERVIEW
11.2.2. REVENUE ANALYSIS
11.2.3. PRODUCT PORTFOLIO
11.2.4. RECENT DEVELOPEMENTS
11.2.5. DATA BRIDGE ANALYSIS
11.3. BOSTON SCIENTIFIC
11.3.1. COMPANY OVERVIEW
11.3.2. REVENUE ANALYSIS
11.3.3. PRODUCT PORTFOLIO
11.3.4. RECENT DEVELOPEMENTS
11.3.5. DATA BRIDGE ANALYSIS
11.4. GE HEALTHCARE
11.4.1. COMPANY OVERVIEW
11.4.2. REVENUE ANALYSIS
11.4.3. PRODUCT PORTFOLIO
11.4.4. RECENT DEVELOPEMENTS
11.4.5. DATA BRIDGE ANALYSIS
11.5. KONINKLIJKE PHILIPS N.V..
11.5.1. COMPANY OVERVIEW
11.5.2. REVENUE ANALYSIS
11.5.3. PRODUCT PORTFOLIO
11.5.4. RECENT DEVELOPEMENTS
11.5.5. DATA BRIDGE ANALYSIS
11.6. MEDTRONIC, INC.
11.6.1. COMPANY OVERVIEW
11.6.2. REVENUE ANALYSIS
11.6.3. PRODUCT PORTFOLIO
11.6.4. RECENT DEVELOPEMENTS
11.6.5. DATA BRIDGE ANALYSIS
11.7. ST. JUDE MEDICAL
11.7.1. COMPANY OVERVIEW
11.7.2. REVENUE ANALYSIS
11.7.3. PRODUCT PORTFOLIO
11.7.4. RECENT DEVELOPEMENTS
11.7.5. DATA BRIDGE ANALYSIS
11.8. SIEMENS AG
11.8.1. COMPANY OVERVIEW
11.8.2. REVENUE ANALYSIS
11.8.3. PRODUCT PORTFOLIO
11.8.4. RECENT DEVELOPEMENTS
11.8.5. DATA BRIDGE ANALYSIS
11.9. MICROPORT SCIENTIFIC CORPORATION
11.9.1. COMPANY OVERVIEW
11.9.2. REVENUE ANALYSIS
11.9.3. PRODUCT PORTFOLIO
11.9.4. RECENT DEVELOPEMENTS
11.9.5. DATA BRIDGE ANALYSIS
11.10. OSYPKA AG
11.10.1. COMPANY OVERVIEW
11.10.2. REVENUE ANALYSIS
11.10.3. PRODUCT PORTFOLIO
11.10.4. RECENT DEVELOPEMENTS
11.10.5. DATA BRIDGE ANALYSIS
11.11. ENDOSENSE SA
11.11.1. COMPANY OVERVIEW
11.11.2. REVENUE ANALYSIS
11.11.3. PRODUCT PORTFOLIO
11.11.4. RECENT DEVELOPEMENTS
11.11.5. DATA BRIDGE ANALYSIS
11.12. ATRICURE, INC.
11.12.1. COMPANY OVERVIEW
11.12.2. REVENUE ANALYSIS
11.12.3. PRODUCT PORTFOLIO
11.12.4. RECENT DEVELOPEMENTS
11.12.5. DATA BRIDGE ANALYSIS
11.13. CARDIOFOCUS, INC.
11.13.1. COMPANY OVERVIEW
11.13.2. REVENUE ANALYSIS
11.13.3. PRODUCT PORTFOLIO
11.13.4. RECENT DEVELOPEMENTS
11.13.5. DATA BRIDGE ANALYSIS
11.14. MOGUL ENTERPRISES, INC.
11.14.1. COMPANY OVERVIEW
11.14.2. REVENUE ANALYSIS
11.14.3. PRODUCT PORTFOLIO
11.14.4. RECENT DEVELOPEMENTS
11.14.5. DATA BRIDGE ANALYSIS
11.15. PIONEER MEDICAL DEVICES AG
11.15.1. COMPANY OVERVIEW
11.15.2. REVENUE ANALYSIS
11.15.3. PRODUCT PORTFOLIO
11.15.4. RECENT DEVELOPEMENTS
11.15.5. DATA BRIDGE ANALYSIS
11.16. CATHEFFECTS INC
11.16.1. COMPANY OVERVIEW
11.16.2. REVENUE ANALYSIS
11.16.3. PRODUCT PORTFOLIO
11.16.4. RECENT DEVELOPEMENTS
11.16.5. DATA BRIDGE ANALYSIS
11.17. JAPAN LIFELINE CO. LTD
11.17.1. COMPANY OVERVIEW
11.17.2. REVENUE ANALYSIS
11.17.3. PRODUCT PORTFOLIO
11.17.4. RECENT DEVELOPEMENTS
11.17.5. DATA BRIDGE ANALYSIS
12. APPENDIX
13. ABOUT DATA BRIDGE MARKET RESEARCH
